Early Increase in Blood Supply in Patients With Barrett's Esophagus
EIBS in BE
Detectable Esophageal Early Increase in Blood Supply (EIBS) in Patients With Barrett's Esophagus
1 other identifier
observational
90
1 country
1
Brief Summary
The purpose of this study is to determine if early Barrett's specialized intestinal metaplasia can be detected by measuring early increased blood supply of the esophageal tissue, with 4 Dimensional Elastic Light-Scattering Fingerprinting, (4D-ELF) technology in real time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 24, 2010
CompletedFirst Posted
Study publicly available on registry
August 26, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedApril 22, 2016
April 1, 2016
2.8 years
August 24, 2010
April 21, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
determine if early increase blood supply (EIBS)can predict presence of Dysplasia
To determine if early increase blood supply (EIBS), as measured in Barrett's glandular mucosa segment, can predict the presence of Dysplasia in patients with known diagnosis of Barrett's esophagus (BE).
10 minutes during standard upper endoscopy
Secondary Outcomes (1)
determine if EIBS can predict presence of BE in patients undergoing upper endoscopy
10 minutes
Study Arms (3)
NoBE (control)
BE without dysplasia
BE with dysplasia
Eligibility Criteria
Control Population: Patients with no Barrett's metaplasia scheduled for upper endoscopy at Mayo Clinic Jacksonville. Experimental Population: Patients with biopsy-proven Barrett's esophagus and previously scheduled for upper endoscopy at Mayo Clinic Jacksonville.
You may qualify if:
- age 18 years or older,
- informed written consent,
- patient scheduled for previously planned upper endoscopy
You may not qualify if:
- liver disease;
- gastric antral vascular ectasia (GAVE);any known non-esophageal aerodigestive malignancy;
- severe cardiopulmonary disease precluding endoscopy; presence of conditions not allowing biopsy (e.g. coagulation disorder);
- known familial polyposis syndrome (FAP, HNPCC, Juvenile polyposis, etc.);
- known pregnancy or sexually active females of childbearing age who are not practicing an accepted form of birth control.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Jacksonville, Florida, 32224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine, Mayo College of Medicine, Director of Endoscopy, Mayo Clinic Florida
Study Record Dates
First Submitted
August 24, 2010
First Posted
August 26, 2010
Study Start
June 1, 2010
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
April 22, 2016
Record last verified: 2016-04